In a study of 7 ms patients (small!), all tested positive for peripheral B cell tolerance defect. Two also tested positive for central B cell tolerance defect. Study authors propose those with only peripheral B cell tolerance defect will respond favorably and for a longer term to treatment with rituximab. They surmise the new B cells will be normal in those with peripheral B cell tolerance issues...and B cells will continue to be abnormal in those with central B cell tolerance issues. Might this explain different reactions to rituximab (if inability of rituximab to cross the bbb in adequate amounts can't be to blame)?
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668812/
MS-b cell tolerance defect-rituximab efficacy
-
- Family Elder
- Posts: 1190
- Joined: Tue Oct 09, 2012 6:33 am
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 11346 Views
-
Last post by NHE
-
- 0 Replies
- 1078 Views
-
Last post by NHE
-
- 0 Replies
- 1371 Views
-
Last post by frodo
-
- 0 Replies
- 10194 Views
-
Last post by NHE
-
- 0 Replies
- 1015 Views
-
Last post by frodo
-
- 0 Replies
- 1848 Views
-
Last post by Petr75
-
- 0 Replies
- 1027 Views
-
Last post by frodo
-
- 7 Replies
- 2459 Views
-
Last post by jimmylegs
-
- 1 Replies
- 1879 Views
-
Last post by frodo